12th week of 2011 patent applcation highlights part 37 |
Patent application number | Title | Published |
20110071168 | NITRIC OXIDE DONORS FOR INDUCING NEUROGENESIS - There is provided a method of promoting neurogenesis by administering a therapeutic amount of a nitric oxide donor compound to a patient in need of neurogenesis promotion. Also provided is a compound for providing neurogenesis having an effective amount of a nitric oxide donor sufficient to promote neurogenesis. A nitric oxide compound for promoting neurogenesis is also provided. Further, a method of augmenting the production of brain cells and facilitating cellular structural and receptor changes by administering an effective amount of a nitric oxide donor compound to a site in need of augmentation is provided. There is provided a method of increasing both neurological and cognitive function by administering an effective amount of a nitric oxide donor compound to a patient. | 2011-03-24 |
20110071169 | Preparation of polymorphic form of lapatinib ditosylate - The present invention is directed to two novel polymorph form (Form A and Form B) of lapatinib ditosylate, wherein Form A is the hydrate ditosylate salt of lapatinib, and Form B is anhydrate ditosylate salt of lapatinib. The present invention is further directed to amorphous form of lapatinib ditosylate and its solid dispersion. The present invention further provides processes for the preparation of Form A, Form B, Amorphous form and solid dispersion of lapatinib ditosyalte, and a pharmaceutical composition comprising the said forms. Form A and Form B were characterized by X-RPD, DSC, TGA and FT-IR, and can be prepared from recrystallizing lapatinib ditosylate in a mixture of tetrahydrofuran (THF) and water. | 2011-03-24 |
20110071170 | TRICYCLIC PYRAZOLOPYRIMIDINE DERIVATIVES - A pyrazolopyrimidine compound represented by formula (1) that inhibits the function of HSP90 as a chaperone protein and that has antitumor activity, a medicament comprising a compound represented by formula (1), a pharmaceutical composition comprising a compound represented by formula (1), and a method for treating cancer using a compound represented by formula (1). | 2011-03-24 |
20110071171 | 2H- PYRIMIDO [2, 1-B] QUINAZOLIN-2-ONE DERIVATIVES AND THEIR USE AS PLATELET ANTI-AGGREGATIVE AGENTS - This invention relates to the discovery of substituted analogues of the selective platelet lowering agent anagrelide with reduced potential for cardiovascular side-effects which should lead to improved patient compliance and safety in the treatment of myeloproliferative diseases. More specifically, the present invention relates to certain imidazoquinazoline derivatives which have the general formula shown below wherein the substituents have the meanings defined in claim | 2011-03-24 |
20110071172 | SUBSTITUTED QUINAZOLINES AS BLOOD PLATELET LOWERING AGENTS - This invention relates to the discovery of substituted analogues of the selective platelet lowering agent anagrelide with reduced potential for cardiovascular side-effects which should lead to improved patient compliance and safety in the treatment of myeloproliferative diseases. More specifically, the present invention relates to certain imidazoquinazoline derivatives which have the general formula shown below wherein the substituents have the meanings defined in claim (I): and which have utility as platelet lowering agents in humans. The compounds of the present invention function by inhibiting megakaryocytopoeisis and hence the formation of blood platelets. | 2011-03-24 |
20110071173 | IMIDAZOQUINAZOLINE DERIVATIVES AS ANAGRELIDE ANALOGUES FOR THE TREATMENT OF MYELOPROLIFIC DISEASES AND THROMBOTIC DISEASES - This invention relates to the discovery of substituted analogues of the selective platelet lowering agent anagrelide with reduced potential for cardiovascular side-effects which should lead to improved patient compliance and safety in the treatment of myeloproliferative diseases. More specifically, the present invention relates to certain imidazoquinazoline derivatives which have the general formula shown below wherein the substituents have the meanings defined in claim | 2011-03-24 |
20110071174 | SUBSTITUTED QUINAZOLINES - This invention relates to the discovery of substituted analogues of the selective platelet lowering agent anagrelide with reduced potential for cardiovascular side-effects which should lead to improved patient compliance and safety in the treatment of myeloproliferative diseases. More specifically, the present invention relates to certain imidazoquinazoline derivatives which have the general formula shown below wherein the substituents have the meanings defined in claim | 2011-03-24 |
20110071175 | Indoles and Their Therapeutic Use - Compound of formula (I) are ligands of the CRTH2 receptor, useful inter alia for treatment of inflammatory conditions. Wherein X is —SO | 2011-03-24 |
20110071176 | PHARMACEUTICAL COMPOSITION COMPRISING OMEGA-3 FATTY ACID AND HYDROXY-DERIVATIVE OF A STATIN AND METHODS OF USING SAME - In various embodiments, the present invention provides compositions and methods for treating and/or preventing a cardiovascular-related disease in subject in need thereof. | 2011-03-24 |
20110071177 | FUNGICIDAL ACTIVE SUBSTANCE COMBINATION - Methods of controlling fungi with an active compound combination that includes trifloxystrobin and pyrimethanil. | 2011-03-24 |
20110071178 | Methods and Compounds for Modulating Cannabinoid Activity - Disclosed are compounds and compositions that inhibit the action of monoacylglycerol lipase (MGL) and fatty acid amide hydrolase (FAAH), methods of inhibiting MGL and FAAH, methods of modulating cannabinoid receptors, and methods of treating various disorders related to the modulation of cannabinoid receptors. | 2011-03-24 |
20110071179 | MACROCYCLIC INHIBITORS OF JAK - The present invention relates to the use of novel macrocyclic compounds of Formula I, | 2011-03-24 |
20110071180 | SUB-TYPE SELECTIVE AMIDES OF DIAZABICYCLOALKANES - The present invention relates to compounds of the following formula (I) that bind to and modulate the activity of neuronal nicotinic acetylcholine receptors, to processes for preparing these compounds, to pharmaceutical compositions containing these compounds, and to methods of using these compounds for treating a wide variety of conditions and disorders, including those associated with dysfunction of the central nervous system (CNS). | 2011-03-24 |
20110071181 | EFFERVESCENT ORAL OPIATE DOSAGE FORMS AND METHODS OF ADMINISTERING OPIATES - Opiate containing dosage forms and methods using same are described. These dosage forms include substantially less opiates by weight than known oral formulations. These dosage forms are intended for oral administration across the oral mucosa. | 2011-03-24 |
20110071182 | Inhibitors of AKT Activity - Invented are novel heterocyclic carboxamide compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis. | 2011-03-24 |
20110071183 | MANUFACTURE OF LOZENGE PRODUCT WITH RADIOFREQUENCY - The present invention features a process for making a lozenge product including the steps of forming a powder blend containing an amorphous carbohydrate polymer into the desired shape of the lozenge product and applying radiofrequency energy to the shape for a sufficient period of time to soften or melt said amorphous carbohydrate polymer to fuse the shape into said lozenge product. | 2011-03-24 |
20110071184 | MANUFACTURE OF TABLET IN A DIE UTILIZING RADIOFREQUENCY ENERGY AND MELTABLE BINDER - The present invention features a process for making a tablet by (i) compacting a powder blend in a die to form a tablet shape, wherein the powder blend contains a pharmaceutically active agent and a meltable binder and (ii) applying radiofrequency energy to the tablet shape for a sufficient period of time to soften or melt the binder within said tablet shape to form the tablet. | 2011-03-24 |
20110071185 | MANUFACTURE OF TABLET IN A DIE UTILIZING POWDER BLEND CONTAINING WATER-CONTAINING MATERIAL - The present invention features the present invention features a process for making a tablet by compacting a powder blend in a die platen to form a tablet shape, wherein the powder blend includes a pharmaceutically active agent and a water-containing material, and applying energy to the tablet shape for a sufficient period of time to heat the water-containing material within the tablet shape above its dehydration temperature to form the tablet. | 2011-03-24 |
20110071186 | ORGANIC COMPOUNDS - This invention is directed to ophthalmic compositions comprising an ascomycin for once-a-day administration. | 2011-03-24 |
20110071187 | 3-SUBSTITUTED-2(ARYLALKYL)-1-AZABICYCLOALKANES AND METHODS OF USE THEREOF - The present invention relates to 3-substituted-2-(arylalkyl)-1-azabicycloalkanes, methods of preparing the compounds and methods of treatment using the compounds. The azabicycloalkanes generally are azabicycloheptanes, azabicyclooctanes, or azabicyclononanes. The aryl group in the arylalkyl moiety is a 5- or 6-membered ring heteroaromatic, preferably 3-pyridinyl and 5-pyrimidinyl moieties, and the alkyl group is typically a C | 2011-03-24 |
20110071188 | 3-SUBSTITUTED-2(ARYLALKYL)-1-AZABICYCLOALKANES AND METHODS OF USE THEREOF - The present invention relates to 3-substituted-2-(arylalkyl)-1-azabicycloalkanes, methods of preparing the compounds and methods of treatment using the compounds. The azabicycloalkanes generally are azabicycloheptanes, azabicyclooctanes, or azabicyclononanes. The aryl group in the arylalkyl moiety is a 5- or 6-membered ring heteroaromatic, preferably 3-pyridinyl and 5-pyrimidinyl moieties, and the alkyl group is typically a C | 2011-03-24 |
20110071189 | 3-SUBSTITUTED-2(ARYLALKYL)-1-AZABICYCLOALKANES AND METHODS OF USE THEREOF - The present invention relates to 3-substituted-2-(arylalkyl)-1-azabicycloalkanes, methods of preparing the compounds and methods of treatment using the compounds. The azabicycloalkanes generally are azabicycloheptanes, azabicyclooctanes, or azabicyclononanes. The aryl group in the arylalkyl moiety is a 5- or 6-membered ring heteroaromatic, preferably 3-pyridinyl and 5-pyrimidinyl moieties, and the alkyl group is typically a C | 2011-03-24 |
20110071190 | BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS - The invention provides compounds of formula I: | 2011-03-24 |
20110071191 | INSECTICIDAL COMPOUNDS - A compound of formula (I): wherein R | 2011-03-24 |
20110071192 | Therapeutic Agents Useful for Treating Pain - A compound of formula: | 2011-03-24 |
20110071193 | SPOT-ON PESTICIDE COMPOSITION - A spot-on pesticide composition for animals, specifically mammals, including dogs and cats, which composition comprises a combination of active components, including fipronil and a pyrethroid, and optionally an insect growth regulator, in doses and proportions which are parasiticidally effective against a variety of insects and pests, and in a formulation which is convenient for local application to the animal's skin, preferably localized over a small surface area. | 2011-03-24 |
20110071194 | Chemical Compounds 572 - Compounds of formula (I): | 2011-03-24 |
20110071195 | NOVEL ALKENE OXINDOLE DERIVATIVES - The present invention provides compounds of formula (I), | 2011-03-24 |
20110071196 | Compounds Which Selectively Modulate The CB2 Receptor - Compounds of formula (I) | 2011-03-24 |
20110071197 | BIS-ARYL COMPOUNDS FOR USE AS MEDICAMENTS - There is provided compounds of formula I, wherein ring A, D | 2011-03-24 |
20110071198 | NICOTINIC ACID RECEPTOR LIGANDS - The present invention relates, in general, to nicotinic acid receptor ligands and, in particular, to ligands that have a relative efficacy for activating a G-protein-coupled receptor function (e.g., signaling) that is greater than their relative efficacy for stimulating β-arrestin function (e.g., recruitment and/or signaling). The invention further relates to the use of such “biased ligands” to decrease triglycerides levels and to potentially increase high density lipoprotein (HDL) levels in patients and potentially lower low density lipoprotein (LDL) and/or very low density lipoprotein (VLDL) levels. In addition, the invention relates to methods of identifying such “biased ligands”. | 2011-03-24 |
20110071199 | Thiophenyl Sulfonamides for the Treatment of Alzheimer's Disease - There is provided a series of novel α-(N-sulfonamido)acetamide compounds of the Formula (I) | 2011-03-24 |
20110071200 | 3-AMINO-BENZO [D] ISOTHIAZOLE DIOXIDE DERIVATIVES AND THEIR USE AS PESTICIDES - A compound of Formula (I) or Formula (II) where W is C—R | 2011-03-24 |
20110071201 | PHENOL-CONTAINING AZOLE COMPOSITIONS FOR THE PROTECTION OF INDUSTRIAL MATERIALS - Composition, comprising
| 2011-03-24 |
20110071202 | ANTI-HEPATITIS C VIRUS AGENTS AND ANTI-HIV AGENTS - An anti-hepatitis C virus agent or anti-HIV agent comprising, as an active ingredient, a fullerene derivative which has a nitrogen atom forming a ring together with adjacent bonded carbon atom pairs constituting the carbon cluster skeleton of the fullerene or a quaternary amine salt thereof is provided. | 2011-03-24 |
20110071203 | TRANSMUCOSAL VETERINARY COMPOSITION COMPRISING DETOMIDINE - The present invention relates to a veterinary composition in a semisolid form adapted for transmucosal administration for providing sedation and analgesia in large animals such as horses and cattle. The semisolid transmucosal composition of the invention comprises detomidine or a pharmaceutically acceptable salt thereof as an active ingredient. The composition provides a rapid onset of action while having low irritation potential in the oral mucosa. | 2011-03-24 |
20110071204 | PERCUTANEOUS ABSORPTION PREPARATION - This present invention provides a percutaneous absorption type pharmaceutical preparation which includes 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide as the active ingredient and a backbone for transdermal system, and satisfies at least one of the following conditions (1) and (2). The pharmaceutical preparation of the present invention enables absorption of 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide, which has a low ability to be absorbed from the skin, from the skin into the body continuously and efficiently.
| 2011-03-24 |
20110071205 | Use of Cyclic Ketoenols Against Phytopathogenic Bacteria - The present invention relates to the use of known cyclic ketoenols against phytopathogenic bacteria. | 2011-03-24 |
20110071206 | Modulators of ATP-Binding Cassette Transporters - Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention. | 2011-03-24 |
20110071207 | Oligomer-Aryloxy-Substituted Propanamine Conjugates - The invention relates to (among other things) oligomer-aryloxy-substituted propanamine conjugates and related compounds. A conjugate of the invention, when administered by any of a number of administration routes, exhibits advantages over un-conjugated aryloxy-substituted propanamine compounds. | 2011-03-24 |
20110071208 | LIPID ENCAPSULATED DICER-SUBSTRATE INTERFERING RNA - The present invention provides novel, stable nucleic acid-lipid particles comprising one or more Dicer-substrate dsRNAs and/or small hairpin RNAs (shRNAs), methods of making the particles, and methods of delivering and/or administering the particles (e.g., for the treatment of a disease or disorder). In some embodiments, the nucleic acid-lipid particles of the invention comprise Dicer-substrate dsRNAs and/or shRNAs. In other embodiments, the nucleic acid-lipid particles of the invention comprise Dicer-substrate dsRNAs and/or shRNAs in combination with one or more additional interfering RNAs (e.g., siRNA, aiRNA, and/or miRNA). In further embodiments, the Dicer-substrate dsRNAs and/or shRNAs present in the nucleic acid-lipid particles of the invention are chemically synthesized. | 2011-03-24 |
20110071209 | RNAi Modulation of the RHO-A Gene and Uses Thereof - The invention relates to compositions and methods for modulating the expression of the RhoA gene, and more particularly to the downregulation of RhoA by chemically modified oligonucleotides. | 2011-03-24 |
20110071210 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER OR OTHER DISEASES - The present invention relates to methods and compositions for the treatment of diseases, including cancer, infectious diseases and autoimmune diseases. The present invention also relates to methods and compositions for improving immune function. More particularly, the present invention relates to multifunctional molecules that are capable of being delivered to cells of interest for the treatment of diseases and for the improvement in immune function. | 2011-03-24 |
20110071211 | MicroRNA (miRNA) And Downstream Targets For Diagnostic And Therapeutic Purposes - The present invention relates to a promoter region of a microRNA, the use of a microRNA, in particular miR-21, and related elements for the diagnosis and for the manufacture of a medicament for the treatment and/or prevention of fibrosis and/or fibrosis related diseases. Additionally, the invention concerns antisense oligonucleotides against targets of miR-21. A cell deficient for miR-21, the promoter region and targets of miR-21 and a knock-out organism thereof are also encompassed. Finally, the invention is directed to a method for diagnosing fibrosis and/or fibrosis related diseases and to a method for screening a pharmaceutically active compound for the treatment of fibrosis and/or fibrosis related diseases. The present invention further relates to compositions for use in the treatment, amelioration, and/or prevention of fibrosis. In certain embodiments, the compositions modulate the activity of a miRNA for the treatment, amelioration, and/or prevention of fibrosis. In certain embodiments, the compositions inhibit the activity of miR-21 for the treatment, amelioration, and/or prevention of fibrosis. | 2011-03-24 |
20110071212 | P185NEU-ENCODING DNA AND THERAPEUTICAL USES THEREOF - Plasmids containing sequences encoding different fragments of p185 | 2011-03-24 |
20110071213 | CARD-DOMAIN CONTAINING POLYPEPTIDES, ENCODING NUCLEIC ACIDS, AND METHODS OF USE - The invention provides caspase recruitment domain (CARD)-containing polypeptides and functional fragments thereof, encoding nucleic acid molecules, and specific antibodies. Also provided are screening methods for identifying CARD-associated polypeptides (CAPs), and for identifying agents that alter the association of a CARD-containing polypeptide with itself or with a CAP. Further provided are methods of altering a biochemical process modulated by a CARD-containing polypeptide, and methods of diagnosing a pathology characterized by an increased or decreased level of a CARD-containing polypeptide. | 2011-03-24 |
20110071214 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER - The present invention provides compositions and methods for the treatment of cancer, and is predicated at least in part on the use of gene fusion regions as therapeutic targets. The fusion region target may be physically embodied at the level of DNA, RNA or protein. Typically the fusion region is specific to cancerous or precancerous cells, meaning that any therapy directed to the target may not significantly affect non-cancerous tissue. The fusion region may be targeted by protein or nucleic acid molecules capable of specifically binding to the region. | 2011-03-24 |
20110071215 | COMPOSITIONS AND METHODS FOR DIAGNOSIS, PROGNOSIS AND TREATMENT OF MESOTHELIOMA - Described herein are compositions and methods for the diagnosis and treatment of mesothelioma patients and the prognosis of mesothelioma patients after surgical operation. Specifically the invention relates to microRNA molecules associated with diagnosis, treatment and prognosis of mesothelioma, as well as various nucleic acid molecules relating thereto or derived therefrom. | 2011-03-24 |
20110071216 | RECONSTITUTABLE REVERSE THERMAL GELLING POLYMERS - Biodegradable and bioabsorbable block copolymers, which can be in the form of solid powder or powder wax compositions that can be easily reconstituted into an aqueous polymer solution and exhibit reverse thermal gellation properties upon exposure to elevated temperatures, are provided. Methods of making using these copolymers are also provided. | 2011-03-24 |
20110071217 | Process for the Synthesis of 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-3H-spiro[isoben- zofuran-1,9'-xanthen]-3-one (Rose Bengal) and Related Xanthenes - A new process for the manufacture of iodinated xanthenes in high purity includes a cyclization step followed by an iodination step. No extraction, chromatographic or solvent concentration steps are required, and the intermediate as well as final compounds are isolated via filtration or similar means. The process requires a single organic solvent, and the steps are completed at temperatures below 100° C. The exclusion of chloride ions, of chloride free-radicals, hypochlorite ions, or hypochlorous acid as reagents or from reagents that may generate these species in situ in the presence of oxidants, prevents undesirable impurity formation. Several new compounds have been conceived and isolated using these methods. These new compounds are also formed into new medicaments. | 2011-03-24 |
20110071218 | NOVEL AMINO ACID DERIVATIVES, METHOD FOR PREPARING SAME, AND THERAPEUTIC USE THEREOF - The disclosure relates to novel compounds of the formula (I) R | 2011-03-24 |
20110071219 | Hemostatic Effects of Glucono-Delta-Lactone - Glucono-delta-lactone (GDL) can be used to mediate the human blood coagulation process. In particular, GDL can be used in an assay to determine an individual's risk potential for accelerated blood clotting or as a treatment for conditions related to accelerated clotting potential and/or inflammatory states. | 2011-03-24 |
20110071220 | Use of Tetronic Acid Derivatives for Fighting Insects and Red Spider Mites by Watering on the Ground, Droplet Application or Immersion Application - Compounds of the formula (II) | 2011-03-24 |
20110071221 | METHOD FOR TREATING CONDITIONS MEDIATED BY PPAR USING MACELIGNAN - Disclosed is a method for treating PPAR (peroxisome proliferator activated receptor)mediated diseases, such as diabetes mellitus and diabetic complications, which includes administering to a subject an effective amount of macelignan represented by the following Formula (I): | 2011-03-24 |
20110071222 | POTENTIATORS OF INSULIN SECRETION - The present invention relates to a recognition that an analog of αKG can increase glucose-induced insulin secretion in vitro and in vivo in animals, particularly in mammals, and more particularly in humans and in rodents. By employing the methods of the invention, insulin secretion can be increased. | 2011-03-24 |
20110071223 | BODY COSMETICS FOR WETTED SKIN - A body cosmetic for application to wetted skin after bathing, and the like, which provide high moisturizing effects, spread well to all over the body, and are easy to apply. | 2011-03-24 |
20110071224 | NOVEL GAMMA-SECRETASE INHIBITOR - It is intended to provide a novel compound that has an excellent γ-secretase inhibitory effect and specifically inhibits Aβ production. | 2011-03-24 |
20110071225 | METHOD FOR OBTAINING A SEQUOYITOL-CONTAINING EXTRACT FROM GENUS NEPHROLEPIS AND USES THEREOF - A method for obtaining a sequoyitol-containing extract from a plant of genus | 2011-03-24 |
20110071226 | EMOLLIENT COMPOSITION - The invention relates to an emollient composition for topical use that comprises a combination of glycerol, Vaseline and liquid paraffin as an active principle, in the form of an oil-in-water or water-in-oil emulsion. The invention also relates to: the use thereof for preparing a drug for treating dry skin conditions associated with certain dermatoses such as atopic dermatitis, ichthyosis conditions and psoriasis; the use thereof for preparing a drug for treating small superficial burns; and the use thereof for preparing a drug for preventing and/or treating and/or reducing the frequency and intensity of eczema attacks observed in patients suffering from atopic dermatitis. | 2011-03-24 |
20110071227 | RAPIDLY WETTING MATERIAL CONTAINING HYDROCOLLOID, METHOD FOR THE MANUFACTURE THEREOF AND USE THEREOF - The present invention relates to a method for the production of a quickly wettable material containing natural hydrocolloid in the form of a shaped body, in which a material containing natural hydrocolloid in the form of a shaped body is exposed to a plasma. | 2011-03-24 |
20110071228 | INSECTICIDAL FORMULATIONS WITH IMPROVED LONG-TERM EFFECT ON SURFACES - The present invention relates to compositions for the control of pests, in particular insecticidal suspension concentrates and spray solutions made from them, to processes for their preparation, and to the use of such formulations for the sustained control of animal pests (arthropods) on a variety of surfaces. The present invention furthermore relates to the use of certain polymer dispersions in pesticides, in particular to their use for extending the long-term activity of these compositions when they are applied to surfaces. The present invention furthermore relates to the use of the compositions according to the invention for controlling parasites, in particular ectoparasites, in animals. | 2011-03-24 |
20110071229 | Synthetic Gas Recycle Apparatus and Methods - Processes and apparatuses for synthesizing a hydrocarbon by reacting a carbon-containing feedstock with an oxygen-containing gas stream having a greater molar ratio of oxygen than the feedstock to produce a first synthetic gas comprising carbon monoxide and hydrogen, reacting the first synthetic gas in a shift reaction zone to produce a shifted synthetic gas, optionally but preferably blending a recycled synthetic gas with the shifted synthetic gas to produce a second synthetic gas, reacting the second synthetic gas with a catalyst in a synthesis reaction zone to produce hydrocarbon(s) and a purge gas, passing the purge gas through a separation zone to produce a hydrogen-containing permeate stream having an increased hydrogen molar ratio compared to the purge gas and a methane-containing non-permeate stream having an increased methane molar ratio compared to the purge gas, and reacting the methane-containing non-permeate stream in a reformation zone to produce the recycled synthetic gas. | 2011-03-24 |
20110071230 | Medical Devices Formed From Recycled Medical Waste and Methods of Manufacture - Methods of reclaiming plastic from plastic medical waste containers containing medical waste and manufacturing recycled medical devices are described. Recycled medical devices made from plastic medical waste containers containing medical waste are also described. | 2011-03-24 |
20110071231 | ORGANIC AEROGEL AND COMPOSITION AND METHOD FOR MANUFACTURING THE ORGANIC AEROGEL - A composition for manufacturing an organic aerogel including at least one monomer having at least two substituted or unsubstituted acrylamide groups and a solvent is provided, along with an organic aerogel including a polymeric reaction product of the monomer or monomers. | 2011-03-24 |
20110071232 | ADDITIVE COMPOSITION FOR INCREASING THE STORAGE STABILITY OF ETHYLENICALLY UNSATURATED RESINS - The invention relates to a method of increasing the dark storage stability of a UV-curable composition comprising a) at least one oligomer, co-oligomer, polymer or copolymer having at least one ethylenically unsaturated bond or a mixture thereof; or a mixture of at least one ethylenically unsaturated monomer with at least one oligomer, co-oligomer, polymer or copolymer having at least one ethylenically unsaturated bond; or at least one ethylenically unsaturated monomer or mixture of said monomers, and one or more α-hydroxycycloalkylphenyl ketone or bisacylphosphine oxide photoinitiators, which method comprises adding b) at least one stable sterically hindered nitroxyl free-radical or at least one compound of the benzofuran-2-one type or a mixture of the two compounds. | 2011-03-24 |
20110071233 | HARDENING COMPOSITION - A hardening composition comprising a particulate glass, said glass comprising 10-35% by weight of silica, 10-35% by weight of alumina, 3-30% by weight of zinc oxide, 4-30% by weight of P | 2011-03-24 |
20110071234 | Self-Healing dental restorative formulations and related methods - Dental restorative formulations comprising two additives incorporated into the continuous phase of a dental material. One additive contains a capsule with a radical initiator. The other additive contains a capsule with one or more monomers and a radical accelerator. The dental restorative formulation is applied and polymerized to form a composite. When a disturbance occurs in the dental composite, the capsules of the additives rupture so that the radical accelerator of the second capsule decomposes the radical initiator of the first capsule to polymerize the one or more monomers of the second capsule thereby healing the dental composite. The radical accelerator controls the rate of decomposition of the radical initiator. | 2011-03-24 |
20110071235 | BIODEGRADABLE ALIPHATIC-AROMATIC COPOLYESTERS, METHODS OF MANUFACTURE, AND ARTICLES THEREOF - Biodegradable compositions containing an aliphatic-aromatic copolyester derived from aromatic polyesters. Methods of making the compositions and articles made from the compositions. | 2011-03-24 |
20110071236 | Method for reducing a surface glossiness of an organopolysiloxane-cured article - A method of reducing a surface glossiness of an organopolysiloxane-cured article is provided. The method comprises preparing the liquid organopolysiloxane composition for matting comprising: (A) 100 parts by weight of a thermosetting liquid organopolysiloxane composition having a specific gravity larger than the component (B), and (B) 0.1 to 100 parts by weight of a hollow filler having a melting point of at least 150° C., and a particle size of up to 200 μm, casting the liquid organopolysiloxane composition as a potting material or coating material; and curing the liquid organopolysiloxane composition at a temperature of 10 to 160 C for 30 to 180 minutes, whereby the hollow filler floats to the surface of the organopolysiloxane and forms surface irregularities on the surface of the cured article during curing to provide a surface glossiness of up to 40 in a cured article having a matted surface. | 2011-03-24 |
20110071237 | Flame Resistance Natural Fiber-Filled Thermoplastics with Improved Properties - Flame retardant systems containing brominated flame retardants and chlorinated flame retardants with synergists and char formers are incorporated into wood-filled resins in combination with compatibilizers to enhance physical properties and to increase water extraction resistance and long term durability. Desirable embodiments of the invention relate to brominated and chlorinated flame retardant additives, synergists, and char formers for use in resins, including polyolefins, fillers, wood-filled polyolefins, in particular wood-filled polyolefins comprising over 20% wood flour, in combination with compatibilizers and methods of use of the flame retardants and fillers. The invention includes methods of making and using the composition. | 2011-03-24 |
20110071238 | ALIPHATIC-AROMATIC BIODEGRADABLE POLYESTER - The invention refers to aliphatic-aromatic biodegradable polyesters obtained from aliphatic dicarboxylic acids, aromatic acids of renewable origin and diols, and also to blends of said polyesters with other biodegradable polymers of either natural or synthetic origin. | 2011-03-24 |
20110071239 | INK COMPOSITION AND INKJET RECORDING METHOD - An ink composition comprising:
| 2011-03-24 |
20110071240 | THERMOPLASTIC POLYESTER COMPOSITIONS, METHODS OF MANUFACTURE, AND ARTICLES THEREOF - A thermoplastic polyester composition comprises, based on the total weight of the composition, from 20 to 95 wt. % of a polyester comprising a poly(alkylene terephthalate); from 1 to 35 wt. % of a phosphorous flame retardant consisting of a phosphinate of the formula (I) | 2011-03-24 |
20110071241 | FLAME RETARDANT, OPTICALLY CLEAR THERMOPLASTIC MOLDING COMPOSITION - The present invention relates to a flame-retardant, optically clear thermoplastic molding composition. The composition contains a A) about 60 pbw to about 97 pbw of a polycarbonate, B) about 1 pbw to about 20 pbw of bromine-substituted oligocarbonate, C) about 1 pbw to about 20 pbw of a phosphorus-containing compound and D) about 0.01 pbw to about 1 pbw of at least one alkali or alkaline-earth salt of perfluoroalkane sulfonic acid and optionally E) about 0.01 to about 1 pbw of a phosphite antioxidant/stabilizer. In accordance with UL-94 standard the flame-retardant, optically clear thermoplastic molding composition is rated 5VA at 3.00 mm and V-0 at 2.3 mm, more preferably V-0 at 1.5 mm according to UL-94. | 2011-03-24 |
20110071242 | Method of Fabricating an Electric Insulator With a Polymer Housing Containing Antiozonants - A method of fabricating a composite insulator with a protective housing made of a polymer material incorporating an antioxidant and an antiozonant includes the step consisting in incorporating said antiozonant at a final concentration by weight lying in the range 0.005% to 1%, and said antioxidant at a final concentration by weight lying in the range 0.005% to 1%, said antiozonant being selected from the family of phenylenediamines, and said antioxidant being selected from the family of multifunctional phenolic antioxidants. | 2011-03-24 |
20110071243 | Method for Exfoliating Organoclay to Produce a Nanocomposite - Nano-composites that comprise a thermoplastic polymer (TPO) and an exfoliated organoclay are prepared by a method comprising contacting under exfoliating conditions at least one molten TPO polymer with at least one organoclay and at least one exfoliating agent of H-TEMPO or an amine precursor to H-TEMPO such that the exfoliating agent exfoliates the organoclay. | 2011-03-24 |
20110071244 | AQUEOUS DISPERSION, ITS PRODUCTION METHOD, AND ITS USE - Aqueous dispersions including at least one thermoplastic resin; at least one dispersing agent; and water; wherein the dispersion has a pH of less than 12 are disclosed along with dispersions including at least one thermoplastic resin; at least one dispersing agent; and water wherein the dispersion has a volume average particle size of less than about 5 μm. Some dispersions include less than about 4 percent by weight of the dispersing agent based on the weight of the thermoplastic resin. Other dispersions include at least one propylene-rich alpha-olefin interpolymer; at least one dispersing agent; and water. Methods of making such dispersions are also described. | 2011-03-24 |
20110071245 | Rubber Mixture with Low Heat Build-Up and Method of Producing Tire Parts - A rubber mixture is ideally suited for producing pneumatic vehicle tires, belts, and straps. The rubber mixture has the following composition: 95-100 phr at least of a natural or synthetic polyisoprene, 0-5 PHR at least of an additional polar or non-polar rubber, 1-10 phr silicic acid, 20-40 phr at least of a carbon black having an iodine fraction less than or equal to 120 g/kg and a DBP fraction greater than or equal to 90 cm3/100 g, 0.1-5 phr at least of a plasticizer oil, 0.1-10 phr zinc oxide, and 2-100 phr of other additives. | 2011-03-24 |
20110071246 | Polycarbonate Resin Composition and Preparation Method Thereof - A polycarbonate resin composition with excellent rigidity (flexural strength) and impact resistance, and a method of preparing the same are disclosed. The polycarbonate resin composition includes 1 to 70 parts by weight of a filament filler of 5˜30 mm based on 100 parts by weight of the total amount of a first polycarbonate resin (A) having a weight-average molecular weight of 25,000 g/mol or less, the filament filler (B), and one of a second polycarbonate resin (C) having a weight-average molecular weight of more than 25,000 g/mol and a rubber-modified styrene graft copolymer resin and a styrene copolymer resin (C). The polycarbonate resin composition provides high rigidity and impact strength, and thus is useful to manufacture a variety of molded articles such as mobile products, electronic components, etc. | 2011-03-24 |
20110071247 | RESIN COMPOSITION AND MOLDED ARTICLE COMPRISING THE SAME - A resin composition comprises a polylactic acid resin (A) 75-10 wt %, an aromatic polycarbonate resin (B) 25-90 wt % and a polymer compound to which a glycidyl compound or an acid anhydride is grafted or copolymerized (D) 1-50 wt parts with respect to 100 wt parts of the total of the component (A) and the component (B). | 2011-03-24 |
20110071248 | COPOLYMER, METHOD FOR ITS PRODUCTION, AND WATER/OIL REPELLENT COMPOSITION - To provide a copolymer which is capable of providing an article surface with a dynamic water repellency and which has extremely excellent washing durability of water repellency and oil repellency, while placing little burden on the environment; a method for its production; and a water/oil repellent composition. | 2011-03-24 |
20110071249 | Fast-Drying Ink Composition - A fast-drying ink composition comprising water, a fast-drying solvent mixture including a hydrophilic co-solvent having low enthalpy of evaporation, a surface-active humectant, and a colorant. The hydrophilic co-solvent may be selected from the group consisting of propylene glycol n-propyl ether, tripropylene glycol methyl ether, and dipropylene glycol methyl ether. The surface-active humectant may comprise a hydrophobic end having a repeating unit “n” ranging from 1 to 36 and selected from the group consisting of alkane-based (CH | 2011-03-24 |
20110071250 | COLORANT DISPERSION OF RECORDING INK, AND RECORDING INK USING THE SAME - The present invention provides a colorant dispersion for a recording ink containing at least a dispersant, a colorant, and water, wherein the dispersant is a polycarboxylic acid dispersant containing units represented by formulae (1) to (3): where R1, R2, and R4 are selected from a hydrogen atom and CH3; R3 is selected from a hydrogen atom and a C1-C3 alkyl group; R5 represents a C1-C3 alkyl group; AO and BO represent a C2-C3 oxyalkylene group; M is selected from alkali metal, alkali earth metal, ammonium, and organic amine; m represents an integer of 1 to 30; and n represents an integer of 5 to 50. | 2011-03-24 |
20110071251 | SILICONATED POLYESTERS AND POLYACRYLATES HAVING A LOW VOC - High solids coating compositions are disclosed, based on polymeric resins synthesized by polycondensation or by solution Free Radical Polymerization FRP and/or Atom Transfer Radical Polymerization ATRP. Two pack coatings with low volatile organic content (VOC) are provided, by curing the above mentioned hydroxy functional polymers, also containing other chemical functional groups in the backbone or side chains (such as oxirane, amino, allyl, halogen) with polyisocyanates and/or amino resins cross-linkers. The coatings thus formulated contain less than about 50% by weight of an organic solvent when applied. | 2011-03-24 |
20110071252 | SYSTEM AND METHOD FOR FORMING A COMPOSITION WITH AN OPTIMIZED FILLER - The particle size distribution of a first fly ash is compared to an ideal particle size distribution that was empirically developed to provide a resin melt with a lower viscosity as more fly ash is added. A second fly ash material is similarly compared to the ideal curve and then is blended or optimized to provide an optimum filler for use with a suitable resin or similar material. Additional fly ash materials may be similarly compared and blended. Additional additives may be added for, among other things, foaming and coloration. | 2011-03-24 |
20110071253 | RUBBER COMPOSITION FOR TIRE AND PNEUMATIC TIRE - The present invention provides: a rubber composition for a tire having favorable productivity, excellent heat aging resistance and abrasion resistance, and excellent fuel economy; and a pneumatic tire using the rubber composition. The rubber composition contains neither soluble sulfur nor insoluble sulfur, and contains diene rubber, 1-15 parts by mass of compound 1 represented by formula (1) and 0.1-5 parts by mass of compound 2 represented by formula (2), per 100 parts by mass of the diene rubber, and the amount ratio of compound 1 to compound 2 (compound 1/compound 2) is 1-8. | 2011-03-24 |
20110071254 | CURABLE COMPOSITIONS CONTAINING SILYLATED POLYETHER BLOCK POLYMER-BASED POLYURETHANES - The invention relates to a silylated polyurethane that is manufactured by reacting at least one polyether compound having an OH number per DIN 53783 between 3 and 20 mg KOH/g, made up of at least two polyoxyalkylene blocks A and B, the number of carbon atoms in the alkylene units of blocks A and B differing by at least 1, with one or more isocyanatosilanes of formula (I): OCN—R—Si—(R | 2011-03-24 |
20110071255 | CURABLE COMPOSITION AND PROCESS FOR PRODUCTION OF ORGANOSILICON COMPOUND - The present curable composition comprises an organosilicon compound produced by hydrolysis copolycondensation of (A) a silicon compound R | 2011-03-24 |
20110071256 | COATING COMPOSITION - The invention relates to coating compositions comprising A) 5.0% to 50.0% by weight of epoxy resins which constitute reaction products of bisphenol A and/or bisphenol F with epichlorohydrin, B) 5.0% to 55.0% by weight of water-dilutable epoxy resin hardeners, C) 0.1% to 10.0% by weight of fibres, D) 0% or 0.1% to 5.0% by weight of wax-based open-time extenders, E) 0% or 0.1% to 5.0% by weight of rheology additives, F) 5.0% to 70% by weight of fillers, G) 0% or 0.1% to 20.0% by weight of water and H) 0% to 70% by weight of further additives and/or processing assistants, the sum of the percentages by weight of components A) to H) making 100% by weight, and the rheology additive (component E) or the filler (component F) being replaced by a fumed silica which has been hydrophobicized with HMDS (hexamethyldisilazane) and subsequently structurally modified by means of a ball mill. | 2011-03-24 |
20110071257 | PHOTOCHROMIC COMPOSITIONS, RESINS AND ARTICLES OBTAINED THEREFROM - Compositions that include one or more compounds according to formula I: | 2011-03-24 |
20110071258 | POLY(HYDROXYALKANOIC ACID) PLASTICIZED WITH POLY(TRIMETHYLENE ETHER) GLYCOL - Toughened, plasticized poly(hydroxyalkanoic acid) polymer compositions comprising poly(trimethylene ether) glycol and ethylene ester copolymers are provided. | 2011-03-24 |
20110071259 | POLYMER COMPOSITION - Provided is a polymer composition including (A) an ionomer containing an ethylene/α,β-unsaturated carboxylic acid copolymer and an ethylene/α,β-unsaturated carboxylic acid/α,β-unsaturated carboxylic acid ester terpolymer, and (B) a propylene-based polymer, wherein the mass of constituent units derived from the α,β-unsaturated carboxylic acid ester is from 1 to 4.5% by mass of the entire mass of the ionomer. Through this, a high seal strength may be obtained in a high-temperature range when forming a lock seal, while a high seal strength, as compared with the related art, can be stably obtained over a wide temperature range with a temperature dependence suppressed when forming a peelable seal. | 2011-03-24 |
20110071260 | PROCESS FOR CLEANER PRODUCTION OF CHLORINATED RUBBER WITHOUT USING CARBON TETRACHLORIDE AND WATER - The present invention relates to a green technology to produce chlorinated rubber without using carbon tetrachloride and water by using 1,1,2-trichloroethane as the solvent and iodine as the catalyst. The natural rubber reacts with an excessive amount of gaseous chlorine at 60-100° C. for 3-8 hours and the product is then dried. The method of the present invention complies with the environmental requirements of “The Montreal Protocol on Substances that Deplete the Ozone Layer” by abandoning the usage of CCl | 2011-03-24 |
20110071261 | TRANSPARENT ARTICLES PREPARED FROM THERMOPLASTIC COMPOSITIONS HAVING LOW BIREFRINGENCE - An optical grade article comprises a thermoplastic composition comprising a poly(aliphatic ester)-polycarbonate copolymer comprising 10 to 25 wt % of a soft block ester unit derived from a C | 2011-03-24 |
20110071262 | METHOD FOR PREPARING HIGH-PURITY POLYETHYLENEGLYCOL ALDEHYDE DERIVATIVES - A method for preparing high-purity polyethyleneglycol-alkylenealdehydes and derivatives thereof is provided. | 2011-03-24 |
20110071263 | Process for the manufacture of at least one ethylene derivative compound - Process for the manufacture of at least one ethylene derivative compound starting with a hydrocarbon source according to which: a) the hydrocarbon source is subjected to a simplified cracking which produces a mixture of products containing ethylene and other constituents; b) the mixture of products is fractionated in one fractionation step into one fraction containing almost all the ethylene (fraction A), optionally into one individual fraction of ethane and into one heavy fraction (fraction C); and c) the fraction A is conveyed to the manufacture of at least one ethylene derivative compound. | 2011-03-24 |
20110071264 | Process for Obtaining Modified Molecular Sieves - The invention covers a process for obtaining an alkaline earth or rare earth metal-P-modified molecular sieve (M-P-modified molecular sieve) comprising the following steps:
| 2011-03-24 |
20110071265 | Method of Enhancing Conductivity of Conductive Polymer Product - A method of enhancing the conductivity of various conductive polymer products, such as a conductive polymer product obtained by polymerizing 3,4-ethylenedioxythiophene in an aqueous solution of polystyrenesulfonic acid. The method of enhancing the conductivity of a conductive polymer product includes placing a conductive polymer product, water, an organic solvent compatible with the conductive polymer product, and carbon dioxide gas in a pressure vessel; and applying heat and pressure to an interior of the pressure vessel to bring the carbon dioxide into a supercritical state. | 2011-03-24 |
20110071266 | Curable Organopolysiloxane Composition, Method of Curing Thereof, Semiconductor Device, And Adhesion Promotor - A curable organopolysiloxane composition comprising an organopolysiloxane containing alkenyl groups and phenyl groups, an organohydrogenpolysiloxane, a copolymer of a vinyl monomer and a vinyl monomer with hydrosilyl groups, and a platinum catalyst; a curing process that consists of two or more stages of thermal curing; an optical semiconductor device that has a light-transmitting portion made from a cured body of the aforementioned composition; and an adhesion promoter that consists of a copolymer of a vinyl monomer and a vinyl monomer with hydrosilyl groups. | 2011-03-24 |
20110071267 | Process for Producing Water-Absorbing Polymer Particles with Improved Blood Absorbance by Polymerizing Droplets of a Monomer Solution - A process for producing water-absorbing polymer particles with improved blood absorbence by polymerizing droplets of a monomer solution in a surrounding gas phase, wherein the monomer solution comprises a surfactant. | 2011-03-24 |